Genetic Material Ingredients TRIZ Cases

Combining histone stem-loop with poly(A) signal stabilizes mRNA against degradation, boosting therapeutic protein expression levels in gene therapy.

Knockout pigs host human stem cells to generate personalized cardiac tissue, addressing organ scarcity and transplant rejection risks.

A Syk inhibitor agent promotes mitochondrial respiratory chain supercomplex assembly to enhance muscle strength.

Segmented methylation-free CpG islands maintain open chromatin configurations, preventing silencing and ensuring stable gene expression across tissues.

Controlling PEGylation levels between 400 and 1250 molecules per virion mitigates cardiovascular effects while maintaining transduction efficiency.

Conjugating hyaluronic acid with polyethyleneimine creates a composite carrier that delivers oligonucleic acids efficiently while reducing cytotoxicity.

Intermediary peptides disrupt the beta4 integrin and focal adhesion kinase complex, reducing tumor malignancy while clarifying molecular mechanisms.

Adenovirus delivering shRNA silences mortalin to suppress collagen and elastin synthesis, resolving excessive fibroblast activity driving keloid formation.

Combining oversized adeno-associated virus vectors with proteasome inhibitors to deliver large heterologous nucleic acids.

Stopper DNA sequences outside inverted terminal repeats reduce non-vector DNA packaging, minimizing patient immune responses.

Phenylboronic acid cross-links dissociate in acidic environments to resolve the stability versus release contradiction.

Unprocessed rolling circle amplification products enable direct cellular transfection without purification steps.

Modified AAV1 VP1 capsids improve transduction specificity and efficiency in subcutaneous and visceral adipose tissues.

Computational method filters expressed missense neoepitopes by HLA type and gene classification to identify high-priority therapeutic targets.

Engineered viruses introduce polynucleotides promoting thanotransmission, overcoming immunotherapy resistance by enhancing immune activation.

Removing VGF, Serpin, and Ankyrin genes reduces virulence while maintaining transduction efficiency for safe cancer treatment.

Dual nucleic acid fractions in gene-activated materials resolve dosing accuracy versus transfection efficiency contradictions.

Polyoma virus-like particles cross the blood-brain barrier via receptor-mediated transcytosis, delivering CNS agents without compromising barrier integrity.

Engineered variant AAV capsid polypeptides enhance transduction efficiency in human hepatocytes through targeted sequence mutations.

Recombinant AAV vector incorporates microRNA target sequences to repress transgene expression in dorsal root ganglia.

Pre-infected immune effector cells deliver replication-competent oncolytic viruses directly into tumor tissue.

Lentivirus vector delivers FLI1 and ETV2 transcription factors to reprogram fibroblasts directly into vascular progenitor cells.

Alternative adenovirus serotypes evade pre-existing human immunity while maintaining broad cell type infectivity and stable episomal gene expression.

A sequential filtration process concentrates extracellular enveloped poxviruses while removing cellular debris and animal-derived contaminants.

Segmenting 13 specific genes reduces testing complexity while improving diagnostic precision for East Asian lung adenocarcinoma patients.

Chemically modified double-stranded ribonucleic acid targets Factor V Leiden mutant mRNA for selective degradation, resolving in vivo stability trade-offs.

Enzyme treatment removes nucleic acid contaminants to prevent vector inactivation during concentration, increasing yield.

An extended anticodon loop in synthetic tRNA suppresses nonsense mutations by reading through stop codons, bypassing the delivery limits of long mRNA sequences.

A Nourin gene-based RNA molecular network detects acute coronary syndromes through lncRNA, miRNA, and mRNA interactions.

Administering BRAF inhibitors alongside adoptive T cell therapy up-regulates IGF2R, overcoming resistance in BRAF-mutant melanoma.

A poxvirus expression system integrates foreign peptides downstream of native promoters to enable stable protein production.

Original restriction sites in adenovirus plasmids allow stable transgene insertion outside early gene regions, preserving virus life-cycle and infectivity.

A single cell PCR assay detects individual lentiviral vector integrations to quantify transduced cells directly.

Inhibiting the TSP1-CD47 pathway removes pathological interference with nitric oxide, restoring vasodilation and increasing blood flow to ischemic tissues.

Antisense molecules targeting miR-133a reduce drug resistance and metastasis in CD133-expressing osteosarcoma cells.

N-mer P-motif inserts in engineered AAV capsids reduce liver toxicity by directing vectors specifically to central nervous system cells.

Segmenting rep and cap genes into distinct plasmids resolves the purity versus yield contradiction in commercial-scale rAAV production.

Nucleobase polymers inhibit microRNA-324 to increase Kv4.2 expression, addressing unaddressed molecular mechanisms in neurological disorders.

Measuring baseline telomere lengths in patient cells to calculate adverse reaction likelihood before therapy initiation.

Multi-layer hydrogel capsules encapsulate mammalian cells using optimized surface curvature and pore size.

Segmented minicircle vectors with truncated origins eliminate promiscuous replication in endogenous flora while maintaining high transgene expression levels.

BORIS-derived peptides induce CTLs against stem cell isoforms, resolving selectivity versus complexity trade-offs.

Segmenting driver from passenger mutations via a ten-gene signature resolves heterogeneity noise for precise prognosis.

Spray-dried crosslinked albumin nanospheres maintain drug bioactivity while reducing side effects.

A configurable service usage facility manages application keys and user tokens to track invocable service interactions.

Analyzing circulating microvesicles enables non-invasive cancer diagnosis by extracting biomarkers without invasive tissue biopsies.

Transfecting Pax6, Foxc1, and Six1 mRNA into pluripotent stem cells generates lacrimal gland epithelial cells for functional organ regeneration.

Gene synthesis targeting surface-exposed capsid residues creates diverse AAV libraries that improve liver transduction efficiency while reducing immunogenicity.